Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
暂无分享,去创建一个
Amanda L. Garner | Kim D. Janda | K. Janda | C. Gloeckner | G. Kaufmann | S. Lustigman | Y. Oksov | Christian Gloeckner | Sara Lustigman | Fana B Mersha | L. M. Eubanks | Fana Mersha | Gunnar F. Kaufmann | N. Tricoche | A. Garner | Yelena Oksov | Nancy Tricoche | Lisa M. Eubanks | F. Mersha | Nancy Tricoche
[1] R. Isaac,et al. Unravelling the moulting degradome: new opportunities for chemotherapy? , 2007, Trends in parasitology.
[2] J. McKerrow,et al. Cloning of a Cysteine Protease Required for the Molting of Onchocerca volvulus Third Stage Larvae* , 1996, The Journal of Biological Chemistry.
[3] L. Konaté,et al. Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.
[4] S. Williams,et al. Chitinase genes expressed by infective larvae of the filarial nematodes, Acanthocheilonema viteae and Onchocerca volvulus. , 1996, Molecular and biochemical parasitology.
[5] Steven A. Williams,et al. Characterization of a Novel Filarial Serine Protease Inhibitor, Ov-SPI-1, from Onchocerca volvulus, with Potential Multifunctional Roles during Development of the Parasite* , 2005, Journal of Biological Chemistry.
[6] A. Prince,et al. Onchocerca volvulus: biochemical and morphological characteristics of the surface of third- and fourth-stage larvae. , 1990, Experimental parasitology.
[7] S. Ōmura,et al. The life and times of ivermectin — a success story , 2004, Nature Reviews Microbiology.
[8] D. Boakye,et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.
[9] D. V. van Aalten,et al. Natural product family 18 chitinase inhibitors. , 2005, Natural product reports.
[10] C. Chong,et al. New uses for old drugs , 2007, Nature.
[11] H. van den Bossche,et al. Closantel, a new antiparasitic hydrogen ionophore [proceedings]. , 1979, Archives internationales de physiologie et de biochimie.
[12] M. Boussinesq,et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.
[13] C. Mackenzie,et al. Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. , 2002, Acta tropica.
[14] Jing Liu,et al. RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting. , 2004, Molecular and biochemical parasitology.
[15] Paul A Wender,et al. Function-oriented synthesis, step economy, and drug design. , 2008, Accounts of chemical research.
[16] S. Sakuda,et al. Expression and Secretion of a Larval-specific Chitinase (Family 18 Glycosyl Hydrolase) by the Infective Stages of the Parasitic Nematode, Onchocerca volvulus * , 2001, The Journal of Biological Chemistry.
[17] S. Gåseidnes,et al. Structural insights into the catalytic mechanism of a family 18 exo-chitinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Gooday,et al. Chitin in egg shells of Onchocerca gibsoni and Onchocerca volvulus. , 1987, Molecular and biochemical parasitology.
[19] D. Boakye,et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study , 2007, The Lancet.
[20] P. Loiseau,et al. Lymphotropic antifilarial agents derived from closantel and chlorambucil. , 1997, International journal for parasitology.
[21] I. Fairweather,et al. The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver flukeFasciola hepatica , 2004, Parasitology Research.
[22] R. Fimmers,et al. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study , 2007, Medical Microbiology and Immunology.
[23] R. Lucius,et al. Essential Role of Chitinase in the Development of the Filarial Nematode Acanthocheilonema viteae , 2007, Infection and Immunity.
[24] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[25] J. Foster,et al. The chitin synthase genes chs-1 and chs-2 are essential for C. elegans development and responsible for chitin deposition in the eggshell and pharynx, respectively. , 2005, Developmental biology.
[26] María-Gloria Basáñez,et al. River Blindness: A Success Story under Threat? , 2006, PLoS medicine.
[27] Phillips,et al. Cloning and expression of a Streptomyces plicatus chitinase (chitinase-63) in Escherichia coli. , 1988, The Journal of biological chemistry.
[28] S. Ōmura. Ivermectin: 25 years and still going strong. , 2008, International journal of antimicrobial agents.
[29] R. Pink,et al. Opportunities and Challenges in Antiparasitic Drug Discovery , 2005, Nature Reviews Drug Discovery.
[30] J. Foster,et al. Parasitic nematodes have two distinct chitin synthases. , 2005, Molecular and biochemical parasitology.
[31] D. Boakye,et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.
[32] R. Martin,et al. Modes of action of anthelmintic drugs. , 1997, Veterinary journal.
[33] Peter J. Hotez,et al. Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden , 2009, PLoS neglected tropical diseases.
[34] S. Ōmura,et al. Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases. , 2004, Chemistry & biology.
[35] M. Cotreau,et al. The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans , 2003, Journal of clinical pharmacology.
[36] Akira Isogai,et al. The structure of allosamidin, a novel insect chitinase inhibitor, produced by Streptomyces Sp. , 1986 .
[37] K. Mehta,et al. Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae , 1995, Antimicrobial agents and chemotherapy.
[38] A. Hoerauf,et al. Of Mice, Cattle, and Humans: The Immunology and Treatment of River Blindness , 2008, PLoS neglected tropical diseases.
[39] D. Kaslow,et al. Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Taylor,et al. Pharmacokinetics of a novel closantel/ivermectin injection in cattle. , 2006, Journal of veterinary pharmacology and therapeutics.
[41] K. Spindler,et al. Chitin metabolism: a target for drugs against parasites , 2004, Parasitology Research.
[42] Adam R Renslo,et al. Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.
[43] Solomon Nwaka,et al. Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.
[44] A. E. Bianco,et al. Chitinase is stored and secreted from the inner body of microfilariae and has a role in exsheathment in the parasitic nematode Brugia malayi , 2008, Molecular and biochemical parasitology.